XNCR FY 2019 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$157M+285.9% YoY

Gross Profit

$38M24.3% margin

Operating Income

$14M8.8% margin

Net Income

$27M17.2% margin

EPS (Diluted)

$0.46

Cash Flow

Operating Cash Flow

$64M

Free Cash Flow

$53M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$670M

Total Liabilities

$77M

Stockholders' Equity

$593M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$157M	$41M	+285.9%
Gross Profit	$38M	-$57M	+167.0%
Operating Income	$14M	-$79M	+117.4%
Net Income	$27M	-$70M	+138.2%